| Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction S Karnewar, PK Neeli, D Panuganti, S Kotagiri, S Mallappa, N Jain, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 134 | 2018 |
| AMPK inhibits MTDH expression via GSK 3β and SIRT 1 activation: potential role in triple negative breast cancer cell proliferation PN Gollavilli, AK Kanugula, R Koyyada, S Karnewar, PK Neeli, ... The FEBS journal 282 (20), 3971-3985, 2015 | 57 | 2015 |
| Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials N Sobhani, B Scaggiante, R Morris, D Chai, M Catalano, DR Tardiel-Cyril, ... Cancer Treatment Reviews, 102429, 2022 | 56 | 2022 |
| AR-V7 in metastatic prostate cancer: a strategy beyond redemption N Sobhani, PK Neeli, A D’angelo, M Pittacolo, M Sirico, IC Galli, ... International journal of molecular sciences 22 (11), 5515, 2021 | 56 | 2021 |
| The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects B Lu, JM Lim, B Yu, S Song, P Neeli, N Sobhani, P K, SR Bonam, ... Frontiers in immunology 15, 1332939, 2024 | 42 | 2024 |
| Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in … S Karnewar, S Pulipaka, S Katta, D Panuganti, PK Neeli, R Thennati, ... Atherosclerosis 356, 28-40, 2022 | 33 | 2022 |
| A novel metadherinΔ7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFĸB-SIRT3 axis PK Neeli, PN Gollavilli, S Mallappa, SG Hari, S Kotamraju Oncogene 39 (10), 2088-2102, 2020 | 33 | 2020 |
| Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization S Mallappa, PK Neeli, S Karnewar, S Kotamraju Molecular carcinogenesis 58 (7), 1118-1133, 2019 | 30 | 2019 |
| Expanding anti-CD38 immunotherapy for lymphoid malignancies MZYL X Wang, X Yu, W Li, P Neeli, M Liu, L Li J Exp Clin Cancer Res, 2022 | 25 | 2022 |
| p53 antibodies as a diagnostic marker for cancer: A meta-analysis N Sobhani, G Roviello, A D’angelo, R Roudi, PK Neeli, D Generali Molecules 26 (20), 6215, 2021 | 13 | 2021 |
| DOT1L regulates MTDH mediated angiogenesis in triple-negative breast cancer: Intermediacy of NF-κB-HIF1α axis PK Neeli, S Sahoo, S Karnewar, G Singuru, S Pulipaka, S Annamaneni, ... The FEBS Journal, 2022 | 10 | 2022 |
| The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma N Jiang, Y Zheng, J Ding, J Wang, F Zhu, M Wang, N Sobhani, P Neeli, ... npj Vaccines 8 (1), 109, 2023 | 7 | 2023 |
| AI-powered discovery of a novel p53-Y220C reactivator Y Li, S Zhou, D Chai, X Wang, P Neeli, X Yu, A Davtyan, K Young Frontiers in Oncology 13, 1229696, 2023 | 7 | 2023 |
| HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+ T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma X Shi, J Ding, Y Zheng, J Wang, N Sobhani, P Neeli, G Wang, J Zheng, ... Iscience 26 (3), 2023 | 6 | 2023 |
| A functional and self-assembling octyl-phosphonium-tagged esculetin as an effective siRNA delivery agent A Shaikh, PK Neeli, G Singuru, S Panangipalli, R Banerjee, SR Maddi, ... Chemical Communications 57 (92), 12329-12332, 2021 | 5 | 2021 |
| sp3‐Rich Glycyrrhetinic Acid Analogues Using Late‐Stage Functionalization as Potential Breast Tumor Regressing Agents S Kallepu, PK Neeli, S Mallappa, NK Nagendla, MK Reddy Mudiam, ... ChemMedChem 15 (19), 1826-1833, 2020 | 5 | 2020 |
| Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2 P Neeli, D Chai, X Wang, N Sobhani, G Udeani, Y Li Iscience 26 (7), 2023 | 4 | 2023 |
| DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice D Chai, X Wang, P Neeli, S Zhou, X Yu, K Sabapathy, Y Li Genes & Diseases 11 (4), 100994, 2024 | 3 | 2024 |
| Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant D Chai, J Wang, C Fan, JM Lim, X Wang, P Neeli, X Yu, KH Young, Y Li Journal of Hematology & Oncology 17 (1), 45, 2024 | 3 | 2024 |
| C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response Q Wang, D Chai, N Sobhani, N Sun, P Neeli, J Zheng, H Tian Frontiers in Physiology, 2410, 2022 | 3 | 2022 |
srigiridhar kotamrajuChief ScientistEmail confirmado em iict.res.in
